rs117470181

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001848.3(COL6A1):​c.588+37A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0126 in 1,538,340 control chromosomes in the GnomAD database, including 1,155 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 94 hom., cov: 33)
Exomes 𝑓: 0.013 ( 1061 hom. )

Consequence

COL6A1
NM_001848.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.370

Publications

3 publications found
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
COL6A1 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bethlem myopathy 1A
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 21-45986722-A-G is Benign according to our data. Variant chr21-45986722-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93881.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.134 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A1NM_001848.3 linkc.588+37A>G intron_variant Intron 4 of 34 ENST00000361866.8 NP_001839.2 P12109A0A384P5H7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkc.588+37A>G intron_variant Intron 4 of 34 1 NM_001848.3 ENSP00000355180.3 P12109

Frequencies

GnomAD3 genomes
AF:
0.0110
AC:
1672
AN:
151434
Hom.:
94
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00110
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0139
Gnomad ASJ
AF:
0.00693
Gnomad EAS
AF:
0.143
Gnomad SAS
AF:
0.0825
Gnomad FIN
AF:
0.00274
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00328
Gnomad OTH
AF:
0.00817
GnomAD2 exomes
AF:
0.0276
AC:
4063
AN:
147114
AF XY:
0.0310
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.0127
Gnomad ASJ exome
AF:
0.00570
Gnomad EAS exome
AF:
0.136
Gnomad FIN exome
AF:
0.00333
Gnomad NFE exome
AF:
0.00349
Gnomad OTH exome
AF:
0.0179
GnomAD4 exome
AF:
0.0128
AC:
17721
AN:
1386788
Hom.:
1061
Cov.:
35
AF XY:
0.0148
AC XY:
10108
AN XY:
684298
show subpopulations
African (AFR)
AF:
0.000826
AC:
26
AN:
31486
American (AMR)
AF:
0.0132
AC:
471
AN:
35644
Ashkenazi Jewish (ASJ)
AF:
0.00633
AC:
159
AN:
25136
East Asian (EAS)
AF:
0.188
AC:
6726
AN:
35712
South Asian (SAS)
AF:
0.0816
AC:
6446
AN:
79036
European-Finnish (FIN)
AF:
0.00352
AC:
140
AN:
39728
Middle Eastern (MID)
AF:
0.0142
AC:
66
AN:
4660
European-Non Finnish (NFE)
AF:
0.00260
AC:
2803
AN:
1077640
Other (OTH)
AF:
0.0153
AC:
884
AN:
57746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
910
1821
2731
3642
4552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0110
AC:
1674
AN:
151552
Hom.:
94
Cov.:
33
AF XY:
0.0133
AC XY:
985
AN XY:
74044
show subpopulations
African (AFR)
AF:
0.00109
AC:
45
AN:
41158
American (AMR)
AF:
0.0140
AC:
214
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00693
AC:
24
AN:
3464
East Asian (EAS)
AF:
0.143
AC:
723
AN:
5068
South Asian (SAS)
AF:
0.0832
AC:
399
AN:
4794
European-Finnish (FIN)
AF:
0.00274
AC:
29
AN:
10580
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00328
AC:
223
AN:
67906
Other (OTH)
AF:
0.00760
AC:
16
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
67
135
202
270
337
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00578
Hom.:
4
Bravo
AF:
0.0108
Asia WGS
AF:
0.0850
AC:
295
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Sep 05, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.91
DANN
Benign
0.37
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117470181; hg19: chr21-47406636; API